Do obsessive–compulsive disorder and Tourette syndrome share a common susceptibility gene? An association study of the BDNF Val66Met polymorphism in the Chinese Han population

References

• Dai M, Xia XB, Xiong SQ. 2012. BDNF regulates GLAST and glutamine synthetase in mouse retinal Muller cells. J Cell Physiol 227:596–603.
   PubMed Web of Science ®Google Scholar
• Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, et al. 2013. Partitioning the heritability of tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet 9:e1003864.
   PubMed Web of Science ®Google Scholar
• Diniz JB, Rosario-Campos MC, Hounie AG, Curi M, Shavitt RG, Lopes AC, et al. 2006. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder. J Psychiatr Res 40:487–493.
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257–269.
   PubMed Web of Science ®Google Scholar
• Epperson CN, Bale TL. 2012. BDNF Val66Met polymorphism and brain-derived neurotrophic factor levels across the female life span: implications for the sex bias in affective disorders. Biol Psychiatry 72:434–436.
   PubMed Web of Science ®Google Scholar
• Ersche KD, Cumming P, Craig KJ, Muller U, Fineberg NA, Bullmore ET, et al. 2012. Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions. J Psychopharmacol (Oxford) 26:887–890.
   PubMed Web of Science ®Google Scholar
• Freeman RD. 2007. Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry 16(Suppl 1):15–23.
   PubMed Web of Science ®Google Scholar
• Geller DA, Biederman J, Faraone S, Agranat A, Cradock K, Hagermoser L, et al. 2001. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis 189:471–477.
   PubMed Web of Science ®Google Scholar
• Goggi J, Pullar IA, Carney SL, Bradford HF. 2003. Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res 968:156–161.
   PubMed Web of Science ®Google Scholar
• Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. 2001. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411:86–89.
   PubMed Web of Science ®Google Scholar
• Gunther J, Tian Y, Stamova B, Lit L, Corbett B, Ander B, et al. 2012. Catecholamine-related gene expression in blood correlates with tic severity in tourette syndrome. Psychiatry Res 200:593–601.
   PubMed Web of Science ®Google Scholar
• Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. 2003a. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 73:370–376.
   PubMed Web of Science ®Google Scholar
• Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. 2003b. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 73:370–376.
   PubMed Web of Science ®Google Scholar
• Hemmings SM, Lochner C, van der Merwe L, Cath DC, Seedat S, Stein DJ. 2013. BDNF Val66Met modifies the risk of childhood trauma on obsessive-compulsive disorder. J Psychiatr Res 47:1857–1863.
   PubMed Web of Science ®Google Scholar
• Hornsey H, Banerjee S, Zeitlin H, Robertson M. 2001. The prevalence of Tourette syndrome in 13–14-year-olds in mainstream schools. J Child Psychol Psychiatry 42:1035–1039.
   PubMed Web of Science ®Google Scholar
• Iervolino AC, Rijsdijk FV, Cherkas L, Fullana MA, Mataix-Cols D. 2011. A multivariate twin study of obsessive-compulsive symptom dimensions. Arch Gen Psychiatry 68:637–644.
   PubMed Web of Science ®Google Scholar
• Ikenouchi-Sugita A, Yoshimura R, Hayashi K, Ueda N, Umene-Nakano W, Hori H, et al. 2009. A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF). World J Biol Psychiatry: Official J World Federation of Societies of Biological Psychiatry 10:977–980.
   PubMed Web of Science ®Google Scholar
• Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, et al. 2009. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD). Am J Med Genet. Part B, Neuropsychiatr Genet 150B: 1050–1062.
   PubMed Web of Science ®Google Scholar
• Leckman JF, Chittenden EH. 1990. Gilles de La Tourette's syndrome and some forms of obsessive-compulsive disorder may share a common genetic diathesis. L’Encephale 16 Spec No:321–323.
   PubMedGoogle Scholar
• Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, et al. 1999. Brain-derived neurotrophic factor- deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96:15239–15244.
   PubMed Web of Science ®Google Scholar
• Maina G, Rosso G, Zanardini R, Bogetto F, Gennarelli M, Bocchio-Chiavetto L. 2010. Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: a case-control study. J Affect Disord 122:174–178.
   PubMed Web of Science ®Google Scholar
• Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Prickaerts J, Oude VRC, et al. 2012. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety. World J Biol Psychiatry: Off J World Federation of Societies of Biological Psychiatry 13:535–543.
   PubMed Web of Science ®Google Scholar
• Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A, et al. 2000. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 36:197–202.
   PubMed Web of Science ®Google Scholar
• Mossner R, Walitza S, Lesch KP, Geller F, Barth N, Remschmidt H, et al. 2005. Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive-compulsive disorder. Int J Neuropsychopharmacol (CINP) 8:133–136.
   PubMed Web of Science ®Google Scholar
• Muller-Vahl KR, Berding G, Kolbe H, Meyer GJ, Hundeshagen H, Dengler R, et al., 2000. Dopamine D2 receptor imaging in Gilles de la Tourette syndrome. Acta Neurol Scand 101: 165–171.
   PubMed Web of Science ®Google Scholar
• Nomura Y, Segawa M. 2003. Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis. Brain Dev 25(Suppl 1):S37–42.
   Google Scholar
• Pauls DL, Raymond CL, Stevenson JM, Leckman JF. 1991. A family study of Gilles de la Tourette syndrome. Am J Hum Genet 48:154–163.
   PubMed Web of Science ®Google Scholar
• Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ. 1986. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry 43:1180–1182.
   PubMed Web of Science ®Google Scholar
• Price RA, Kidd KK, Cohen DJ, Pauls DL, Leckman JF. 1985. A twin study of Tourette syndrome. Arch Gen Psychiatry 42:815–820.
   PubMed Web of Science ®Google Scholar
• Pu L, Liu QS, Poo MM. 2006. BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat Neurosci 9:605–607.
   PubMed Web of Science ®Google Scholar
• Santangelo SL, Pauls DL, Goldstein JM, Faraone SV, Tsuang MT, Leckman JF. 1994. Tourette's syndrome: what are the influences of gender and comorbid obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 33:795–804.
   PubMed Web of Science ®Google Scholar
• Savitz J, Solms M, Ramesar R. 2006. The molecular genetics of cognition: dopamine, COMT and BDNF. Genes Brain Behav 5:311–328.
   PubMed Web of Science ®Google Scholar
• Stengler-Wenzke K, Muller U, Angermeyer MC, Sabri O, Hesse S. 2004. Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD). Eur Arch Psychiatry Clin Neurosci 254:252–255.
   PubMed Web of Science ®Google Scholar
• Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, et al., 2007. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet Part B Neuropsychiatr Genet 144B:1027–1033.
   PubMed Web of Science ®Google Scholar
• Taylor S. 2013. Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies. Mol Psychiatry 18:799–805.
   PubMed Web of Science ®Google Scholar
• Tukel R, Gurvit H, Ozata B, Ozturk N, Ertekin BA, Ertekin E, et al. 2012. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder. Am J Med Genet Part B Neuropsychiatr Genet 159B:850–858.
   PubMed Web of Science ®Google Scholar
• Wendland JR, Kruse MR, Cromer KR, Murphy DL. 2007. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder. Neuropsychopharmacology 32:2543–2551.
   PubMed Web of Science ®Google Scholar